Voyage Medical

STUDY 6

STUDY PERIOD

Start date: September 6, 2022

End date: June 2025

STUDY INFORMATION

Indication: This study is developed to evaluate the efficacy of Xxxx compared to placebo for the treatment of agitation associated with Alzheimer’s disease.

Frequency of Visit:
Screening Visit: 1
In Person Visit: 6

STUDY CRITERIA

Age: 65 to 90 years old

Gender: Both

STUDY DETAILS

Study Number: 006

Study Requirement:
*Diagnosis of probable Alzheimer's disease
*Clinically significant agitation, at the time of screening and for at least 2 weeks prior to baseline

Stipend: Compensation provided to both Subject and Informant

Clinical Research Drives Change

Give Us A Call At 480-306-5000

Get in touch with us